TREM2 and Parkinson disease: In this study, C57BL/6 mice were injected with AAV-TREM2-shRNA to knock down the expression of TREM2 in the substantia nigra of the midbrain by stereotactic injection technique, and then chronic PD mice were established by intraperitoneal injection of MPTP and probenecid.